You are now leaving www.admabiologics.com
The link you have selected will take you outside of ADMA Biologics corporate website. The site you will be entering is intended for U.S. audiences only. Do you wish to continue?
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 05/13/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 05/11/22 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
74 |
| 05/11/22 | 8-K | Current report filing |
|
|
10 |
| 04/28/22 | DEF 14A | Definitive proxy statements |
|
70 | |
| 04/28/22 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
3 | |
| 03/25/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/25/22 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/25/22 | 8-K | Current report filing |
|
|
6 |
| 03/24/22 | 10-K | Annual report pursuant to Section 13 and 15(d) |
|
|
268 |
| 03/24/22 | 8-K | Current report filing |
|
|
11 |
